CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA)
CYNA
CYNA was delisted on the 20th of October, 2016.
30 hedge funds and large institutions have $107M invested in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
7% more funds holding
Funds holding: 28 → 30 (+2)
1% less capital invested
Capital invested by funds: $107M → $107M (-$546K)
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$1.99M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
+$1.23M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$1.12M |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$959K |
| 5 |
AC
Aisling Capital
New York
|
+$702K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$834K |
| 2 |
JGC
J. Goldman & Co
New York
|
-$410K |
| 3 |
GTC
Ghost Tree Capital
New York
|
-$355K |
| 4 |
Goldman Sachs
New York
|
-$209K |
| 5 |
Millennium Management
New York
|
-$190K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Creative Planning
Overland Park,
Kansas
| $4K | – | – | – |
|
|
TRCT
27
Tower Research Capital (TRC)
New York
| $2K | -$5.67K | -373 | -73% |
|
28
Barclays
London,
United Kingdom
| $2K | +$1.52K | +100 | New |
|
29
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
| $1K | +$897 | +59 | New |
|
|
30
Goldman Sachs
New York
| – | -$209K | -12,929 | Closed |
|
31
UBS Group
Zurich,
Switzerland
| – | -$19K | -1,147 | Closed |
|
32
Morgan Stanley
New York
| – | -$12.8K | -842 | -98% |
|
CYNA Hedge Fund Activity: Q4 2015 in Review
30 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) for Q4 2015, worth a combined $107M — down 0.51% from $107M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new CYNA positions and 3 closed out — a net gain of 2 holders — while 7 added to existing stakes and 10 trimmed.
The largest buyer was Tekla Capital Management, adding an estimated $1.99M. The largest seller was Sphera Funds Management, cutting an estimated $834K.
- 30 institutional investors held CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) (CYNA) as of Q4 2015, up from 28 in Q3 2015.
- Funds reported $107M of CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) stock for Q4 2015, down 0.51% quarter-over-quarter.
- 5 funds opened new CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) positions in Q4 2015 and 3 closed out, a net change of +2 holders.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) buyer in Q4 2015 was Tekla Capital Management, an estimated $1.99M added.
- The largest CYNAPSUS THERAPEUTICS INC COM PAR NO PAR (CANADA) seller in Q4 2015 was Sphera Funds Management, an estimated $834K sold.
Based on aggregated 13F filings for Q4 2015.